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I N T R O D U C T I O N
CFTR,  a  member  of  the  ATP-binding  cassette  (ABC) 
transporter superfamily, is an epithelial chloride chan-
nel that plays a critical role in fluid absorption and secre-
tion. Loss-of-function mutations of CFTR result in the 
lethal hereditary disease cystic fibrosis (Riordan et al., 
1989; Welsh and Smith, 1993; Welsh et al., 2001), whereas 
hyperfunction of CFTR chloride channels, usually re-
sulted from bacterial enterotoxins, constitutes the basic 
cause for secretory diarrhea (Bhattacharya, 1995; Barrett 
and Keely, 2000). Therefore, the development of pharma-
cological reagents that can modulate CFTR function 
bears practical implications in clinical medicine.
There has been tremendous progress in developing 
reagents that potentiate CFTR activity in recent years 
(Thiagarajah and Verkman, 2003; Van Goor et al., 2008). 
In fact, one of the compounds is now in stage III clinical 
trial (Van Goor et al., 2009). However, progress in dis-
covering CFTR inhibitors has been slow. Several well-
studied CFTR inhibitors lack specificity and assume low 
potency  (Hwang  and  Sheppard,  1999;  Schultz  et  al., 
1999). These include glibenclamide, diphenylamine-2-
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carboxylate, 5-nitro-2(3-phenylpropyl-amino) benzoate, 
and niflumic acid. They seem to share a common mech-
anism of action, plugging the pore from the cytoplas-
mic side of the channel. High-throughput screening of 
diverse small molecules has made possible the discovery 
of two more selective inhibitors, a thiazolidinone deriv-
ative, or CFTRinh-172 (Ma et al., 2002), and glycine hydra-
zide, or GlyH-101 (Muanprasat et al., 2004), for CFTR. 
Unlike aforementioned pore blockers, GlyH-101 ap-
pears to act on the anion permeation pathway from the 
extracellular side of the channel. On the other hand, 
CFTRinh-172 works from the cytoplasmic side by inhib-
iting CFTR gating (Taddei et al., 2004).
Like other members of the ABC protein family, CFTR 
possesses two nucleotide-binding domains (NBDs), NBD1 
and NBD2, in addition to two transmembrane domains 
(TMDs) that form the permeation pathway for chloride 
ions. Although the transporter members of this family 
use ATP binding and hydrolysis to drive the movement 
of substrate across the membrane, CFTR proteins use 
the same energy-harvesting machinery to drive the 
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The effects of a thiazolidinone derivative, 3-[(3-trifluoromethyl)phenyl]-5-[(4-carboxyphenyl)methylene]-2-thioxo-
4-thiazolidinone (or CFTRinh-172), on cystic fibrosis transmembrane conductance regulator (CFTR) gating were 
studied in excised inside-out membrane patches from Chinese hamster ovary cells transiently expressing wild-type 
and mutant CFTR. We found that the application of CFTRinh-172 results in an increase of the mean closed time 
and a decrease of the mean open time of the channel. A hyperbolic relationship between the closing rate and 
[CFTRinh-172] suggests that CFTRinh-172 does not act as a simple pore blocker. Interestingly, the potency of inhi-
bition increases as the open time of the channel is increased with an IC50 in the low nanomolar range for CFTR 
channels locked in an open state for tens of seconds. Our studies also provide evidence that CFTRinh-172 can bind 
to both the open state and the closed state. However, at least one additional step, presumably reflecting inhibitor-
induced conformational changes, is required to shut down the conductance after the binding of the inhibitor to 
the channel. Using the hydrolysis-deficient mutant E1371S as a tool as the closing rate of this mutant is dramatically 
decreased, we found that CFTRinh-172–dependent inhibition of CFTR channel gating, in two aspects, mimics the 
inactivation of voltage-dependent cation channels. First, similar to the recovery from inactivation in voltage-gated 
channels, once CFTR is inhibited by CFTRinh-172, reopening of the channel can be seen upon removal of the   
inhibitor in the absence of adenosine triphosphate (ATP). Second, ATP induced a biphasic current response on 
inhibitor-bound closed channels as if the ATP-opened channels “inactivate” despite a continuous presence of ATP. 
A simplified six-state kinetic scheme can well describe our data, at least qualitatively. Several possible structural 
mechanisms for the effects of CFTRinh-172 will be discussed.
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mechanism of inhibition than a simple pore occlu-
sion. Our data suggest that the binding of CFTRinh-172 
to either the open or the closed state induces confor-
mational changes that “inactivate” the channel. This 
inactivation emulates the well-established inactivation 
mechanism  for  voltage-gated  cation  channels.  The 
structural and functional implications of our results 
are discussed.
M AT E R I A L S   A N D   M E T H O D S
Cell culture and transient expression of CFTR
NIH3T3 cells stably expressing WT-CFTR channels and Chinese 
hamster ovary (CHO) cells were grown at 37°C and 5% CO2 in 
Dulbecco’s  modified  Eagle’s  medium  supplemented  with  10% 
FBS. WT or mutant CFTR channels were expressed transiently in 
CHO cells. The cDNA constructs were cotransfected with pEGFP-
C3 (Takara Bio Inc.) encoding green fluorescent protein using 
transfection reagent (PolyFect; QIAGEN) according to the manu-
facturer’s protocols. Before patch clamp recordings, cells were 
plated on sterile glass chips in 35-mm tissue culture dishes and in-
cubated at 27°C for 1–2 d.
Inside-out patch clamp recordings
Patch clamp pipettes were made from borosilicate capillary glass 
using a two-stage vertical puller (Narishige). The pipette tips were 
fire polished with a homemade microforge to yield a pipette resis-
tance of 3–5 MΩ measured in the working solution. Before the re-
cording, a glass chip with cells grown on it was placed into a 
continuously perfused chamber on the stage of an inverted mi-
croscope (Olympus). CFTR currents were recorded at room tem-
perature (22–24°C) with an amplifier (EPC9; HEKA). Data were 
filtered at 100 Hz with an eight-pole Bessel filter (Warner Instru-
ments) and captured onto a hard disk at a sampling rate of 500 Hz. 
The membrane potential was held at 60 mV. Downward deflec-
tions in the current trace indicate channel opening. The current 
traces were reversed in polarity for data presentation.
The standard pipette solution contained (in mM): 140 NMDG-
Cl, 2 MgCl2, 5 CaCl2, and 10 HEPES, pH 7.4 with NMDG. The 
bath solution contained (in mM): 145 NaCl, 5 KCl, 2 MgCl2, 1 
CaCl2, 5 glucose, 5 HEPES, and 20 sucrose, pH 7.4 with NaOH. 
The perfusion solution after patch excision contained (in mM): 
150 NMDG-Cl, 10 EGTA, 10 HEPES, 8 TRIS, and 2 MgCl2, pH 7.4 
with NMDG.
Data analysis
The steady-state mean currents used for calculation of the degree 
of inhibition were calculated with IGOR software (WaveMetrics). 
The mean baseline currents were subtracted before the data were 
used for calculations. The degree of inhibition by CFTRinh-172 
was calculated according to the equation:
  % / %,  inhibition    1 I I 1 inh 172 = − ( ) − 0 00 i  
where I0 and Iinh-172 represent uninhibited and inhibited current, 
respectively.
Kinetic parameters were extracted from patches with five or 
fewer simultaneous channel opening steps using a program devel-
oped by L. Csanády (for details, see Csanády, 2000). For a given 
[CFTRinh-172], the mean open (closed) time in the presence 
and absence of CFTRinh-172 was calculated as an average over 
5–10 patches.
All averaged data are presented as means ± SEM; n represents 
the number of patches. Student’s t tests were performed using 
conformational changes involved in the opening and clos-
ing of the gate (Chen and Hwang, 2008; Hwang and 
Sheppard, 2009). The molecular mechanism underlying 
CFTR gating has been extensively studied with numerous 
nucleotide and phosphate analogues (e.g., Aleksandrov 
et al., 2002; Vergani et al., 2003; Zhou et al., 2005; Cai 
et al., 2006; Tsai et al., 2009). The major advantage of 
these reagents is that the site of action is in the ATP-
binding pockets. However, this same feature also lim-
its the mechanistic insights within the role of NBDs in 
CFTR gating. In contrast, CFTRinh-172 does not compete 
with ATP (Taddei et al., 2004). Thus, unraveling how 
CFTRinh-172 works and identifying its site of action 
could shed light on the gating mechanism beyond NBDs.
Despite the high specificity of CFTRinh-172 on CFTR 
gating, very limited studies have been conducted to un-
derstand how it works (Taddei et al., 2004; Caci et al., 
2008). The inhibition was found to be potent, rapid, 
reversible, and voltage independent, despite the fact that 
CFTRinh-172 carries a negative charge. Patch clamp 
experiments  (Taddei  et  al.,  2004)  have  shown  that 
CFTRinh-172 reduces the open probability (Po) but does 
not change the unitary conductance. It was also reported 
that the decrease in Po was caused by an increase of the 
mean closed time with the mean open time being un-
changed. Based on the lack of voltage dependence and 
an absence of changes in the open time, it was proposed 
that CFTRinh-172 affects channel gating rather than oc-
cludes the pore, and that the inhibitor probably acts 
during the closed phase of the gating cycle. However, it is 
strange that the degree of inhibition for G551D and 
G1349D was of the same order of magnitude as that of 
wild-type (WT)-CFTR, despite a very different closed time 
among these three channels (Bompadre et al., 2007).
Another set of experiments was performed to test the 
possibility that CFTRinh-172 interacts with the pore re-
gion of CFTR proteins (Caci et al., 2008). The effect of 
mutations in amino acid residues of the sixth trans-
membrane helix of CFTR on the apparent affinity of 
CFTRinh-172 has been examined. Fluorescence assays 
and whole cell patch clamp experiments have shown 
that mutations of several residues in this segment alter 
the sensitivity to CFTRinh-172. However, the residue in 
this region of CFTR, when mutated, that exhibits the 
most changes in the apparent affinity for CFTRinh-172 
is R347, which does not line the permeation pathway 
(Cotten and Welsh, 1999; Bai et al., 2010).
The purpose of the current work was to elucidate the 
kinetic mechanism of CFTR inhibition by CFTRinh-172. 
Contrary to previous reports, we found that the mean open 
time of the CFTR channel is decreased by CFTRinh-172, 
and that prolongation of the channel open time leads 
to more potent inhibition. Although these findings sup-
port the idea that the inhibitor acts when the channel is 
opened, the nonlinear relationship between the closing 
rate and [CFTRinh-172] implies a more complicated   Kopeikin et al. 661
with a single-exponential function, yielding a time con-
stant of 40 s (42.0 ± 5.3 s; n = 17). The concentration 
dependence of the effect of CFTRinh-172 is shown in 
Fig. 1 B. Fitting the dose–response relationship with the 
Hill equation yields an IC50 of 1.1 µM and a Hill coef-
ficient of 1, results very similar to those reported by 
Taddei et al. (2004). It should be noted that even at 
10 µM (>6 × IC50), the inhibitor did not abolish all the 
current. Also as reported by Taddei et al. (2004), we 
found that the effect of CFTRinh-172 on CFTR is not 
sensitive to the membrane potential (Fig. 1, C and D).
Effects of CFTRinh-172 on single-channel kinetics
Although the results shown in Fig. 1 basically agree with 
what has been reported by Taddei et al. (2004), some 
differences emerged when we examined single-channel 
kinetics of CFTR in the presence of CFTRinh-172. The 
major kinetic effect of CFTRinh-172 on CFTR was re-
ported  to  be  an  increase  of  the  closed  time  without 
changes of the open time. For an inhibitor that only 
prolongs the closed time, a simple three-state scheme, 
Cinh↔C↔O, can be used to explain the results. How-
ever, this scheme will not be sufficient if the open time 
is altered by the inhibitor.
Fig.  2  shows  recordings  of  WT-CFTR  in  inside-out 
membrane patches containing few channels so that in-
dividual openings and closings can be discerned and 
microscopic kinetic parameters can be obtained. Even 
by eye inspection, one can observe a decrease of the open 
time accompanying a prolonged closed time in the pres-
ence of CFTRinh-172. This effect of CFTRinh-172 on the 
open time is even more prominent on P-ATP–opened 
SigmaPlot  (version  4.0;  Systat  Software  Inc.),  and  effects  were 
considered significant if P < 0.05.
Reagents
MgATP, PPi (tetrasodium salt), and PKA were purchased from 
Sigma-Aldrich.  N6-(2-phenylethyl)-ATP  (P-ATP)  was  purchased 
from BioLog Life Science Institute. MgATP and PPi were stored 
as a 250-mM stock solution at 20°C. 10 mM P-ATP stock solution 
was stored at 80°C. The [PKA] used in this study was 1.6 µg/ml.
Online supplemental material
We performed Monte Carlo simulations based on the proposed 
Scheme 3 to reproduce some of our major findings. The online 
supplemental material includes simulated results mimicking ex-
perimental data shown in Figs. 1, 3, 5, 6, 8, and 10. It is available 
at http://www.jgp.org/cgi/content/full/jgp.201010518/DC1.
R E S U LT S
Voltage-independent inhibition of CFTR current  
by CFTRinh-172
We  studied  the  effect  of  CFTRinh-172  on  CFTR  Cl
 
channels in excised inside-out membrane patches from 
CHO cells transfected with cDNA encoding WT or mu-
tant CFTR. The channels were first activated by phos-
phorylation to a steady state with 1.6 µg/ml PKA and 
1 mM MgATP. After activation, patches were exposed to 
1 mM MgATP, and then to 1 mM MgATP plus different 
concentrations of CFTRinh-172. Fig. 1 A shows repre-
sentative recordings where 1 and 10 µM CFTRinh-172 
cause 50 and 90% reduction of the original current, 
respectively, and this inhibition is reversible, as removal 
of the inhibitor recovers all the current. The current re-
covery phase upon washout of the inhibitor can be fitted 
Figure  1.  Voltage-independent   
inhibition  of  WT-CFTR  by 
CFTRinh-172.  (A)  Continuous 
WT-CFTR  current  traces  show-
ing  reversible  inhibition  by  1 
or  10  µM  CFTRinh-172.  In  an 
inside-out  patch  clamp  experi-
ment, after the channels in the 
patch  were  activated  with  1 
mM  MgATP  plus  PKA,  we  ap-
plied 1 mM MgATP, followed by 
1 mM MgATP plus 1 or 10 µM 
CFTRinh-172.  The  current  re-
covery  phase  upon  removal  of   
1  µM  CFTRinh-172  was  fitted 
with  a  single-exponential  func-
tion, yielding a rate constant of 
0.031 s
1 (0.024 ± 0.003 s
1; n = 
17). (B) The concentration de-
pendence  of  CFTR  inhibition 
fitted with the Hill equation with 
IC50 = 1.16 ± 0.09 µM and Hill 
coefficient n = 1.31 ± 0.12. Each data point represents values determined from 6–14 patches. The error bars are smaller than the symbols. 
(Inset) The structure of CFTRinh-172. (C) Representative I-V curves in the presence (red) or absence (blue) of 1 µM CFTRinh-172. 
A voltage ramp over ±100 mV was applied to a patch yielding macroscopic currents. (D) Percent inhibition at different voltages was 
obtained from C. Data between 10 and 10 mV were discarded because of the small size of the signal. Similar observations were made 
in five patches. Inh-172 is the abbreviation for CFTRinh-172 in this and subsequent figures.662 CFTR inhibition by a thiazolidinone derivative
bound channels open with a shorter open time; i.e., 
O’inh↔Cinh↔C↔O (Scheme 2).
Effects of the open time on the apparent affinity  
of CFTRinh-172
The observation that, at a submaximal [CFTRinh-172], 
the degree of inhibition is higher for WT-CFTR opened 
with P-ATP than that with ATP suggests a relationship 
between the stability of the open state and IC50. As 
shown in Fig. 2 C, the decrease of the mean open time 
by CFTRinh-172 is greater if CFTR channels are opened 
with P-ATP instead of ATP.
To  further  explore  this  relationship  between  the 
mean open time and the potency of CFTRinh-172, we 
tested CFTRinh-172 on a CFTR mutant, D1370N-CFTR, 
which exhibits an open time of 1 s (Bompadre et al., 
2005). Fig. 4 A shows a representative current trace with 
two opening steps. Microscopic kinetic analysis revealed 
a mean open time of 1,017.1 ± 45.4 ms (n = 5) for this 
mutant CFTR. Fig. 4 B demonstrates the effects of 1 µM 
CFTRinh-172 on the macroscopic current of D1370N-
CFTR. Compared with WT-CFTR (50% inhibition), 
>80% inhibition was observed at this concentration of 
CFTRinh-172.  This  more  efficacious  inhibition  is  ac-
companied  by  an  even  slower  rate  of  recovery  upon 
washout of CFTRinh-172 in the continuous presence of 
ATP. The time course of current recovery can be fitted 
well with a single-exponential function (Fig. 4 B, red 
line), yielding a rate constant of 0.006 ± 0.001 s
1 (n = 15), 
which is approximately fivefold slower than the rate of 
recovery for WT-CFTR (Fig. 1). This decrease in IC50 
for CFTRinh-172 is best seen with the dose–response 
channels, as this high-affinity ATP analogue increases the 
open time of WT-CFTR (Fig. 2, B and C). At a macro-
scopic level, P-ATP–gated channels also seem more sen-
sitive to CFTRinh-172 (66% inhibition for P-ATP– vs. 51% 
inhibition for ATP-gated channels at 1 µM CFTRinh-172). 
Shortening of the open time implies that the inhibitor 
works when the channel is in the open state and is typi-
cally one of the main characteristics of an open-channel 
blocker. Therefore, it is important to first examine the 
possibility that CFTRinh-172 acts by occluding the pore 
as a simple open-channel blocker.
The mechanism of action for simple pore blockers 
can be described by the minimum scheme C↔O↔B, 
where C↔O and O↔B represent the ATP-dependent 
gating and inhibitor-dependent blocking steps, respec-
tively. This scheme predicts a linear relationship between 
the closing rate of the channel and the concentration of 
the inhibitor as demonstrated for glibenclamide block-
ade of CFTR (Zhou et al., 2002). We measured the 
closing rate (i.e., 1/o) at different [CFTRinh-172]. 
Interestingly, instead of a simple linear relationship be-
tween the closing rate and [CFTRinh-172], our results 
show a hyperbolic relationship (Fig. 3). Because short-
ening of the open time itself suggests that the inhibi-
tor can bind to the open state (also see below), this 
saturation  function  can  be  described  by  a  more  ex-
panded scheme: C↔O↔Oinh↔Iinh (Scheme 1). Here, 
the binding of the inhibitor to the open state (Oinh) by 
itself does not abolish the current, but it may induce 
some conformational changes that result in a non-
conducting or “inactivated” state, Iinh. Alternatively, the 
inhibitor may bind to the closed state, but the inhibitor-
Figure 2.  Effects of CFTRinh-172 on the open time of WT-CFTR. (A and B) Single-channel traces showing a reversible decrease of the 
open time in the presence of CFTRinh-172 for (A) ATP- and (B) P-ATP–gated channels. Dashed lines represent the current level of the 
closed state. (C) The mean open time (o) decrease as a result of 5 µM CFTRinh-172 for channels opened with ATP (n = 10) or P-ATP 
(n = 7). The mean closed time (c) was prolonged by CFTRinh-172 (c = 637.3 ± 59.2 ms in the absence of CFTRinh-172 and 2,580.5 ± 623.4 
ms in the presence of 5 µM CFTRinh-172). For channels opened with P-ATP, c = 670.8 ± 55.8 ms and 2,058.3 ± 254.2 ms in the absence 
and presence of CFTRinh-172, respectively.  Kopeikin et al. 663
The extremely high stability of the inhibited state for 
locked-open channels is also represented in the wash-
out phase of the experiment. Fig. 6 A shows that once 
the locked-open WT channels are inhibited, removal of 
CFTRinh-172 in the continuous presence of ATP results 
in an extremely slow recovery of the current. When we 
fitted the time course of the current recovery phase with 
a single exponential function, the time constant was on 
the order of hundreds of seconds. A similar observation 
was  made  with  E1371S-CFTR  channels  locked  open 
with ATP (Fig. 6 B). One technical difficulty with this 
type of long-lasting experiments is the possibility of run-
down  induced  by  membrane-associated  phosphatases 
(e.g., Weinreich et al.,1999), although during the slow 
relationships (Fig. 4 C) that show a graded leftward shift 
as the mean open time is prolonged.
The results shown in Fig. 4 suggest that the potency of 
CFTRinh-172 is determined by the open time: the lon-
ger the open time, the lower the IC50. For D1370N-
CFTR with an open time of 1 s, the IC50 is already in 
the nanomolar range. We wondered if the potency can 
be  increased  additionally  if  we  further  prolong  the 
open time, which can be accomplished by locking open 
WT-CFTR with ATP and PPi (Tsai et al., 2009). If the hy-
pothesis that the increase in the open time leads to more 
potent inhibition is correct, one can expect a significant 
increase in the potency of CFTRinh-172 for channels 
locked in a stable open state for tens or hundreds of sec-
onds. Fig. 5 A shows a continuous current trace of 
WT-CFTR activated with PKA, ATP, and PPi. Once the 
current reached a steady state, 2 µM CFTRinh-172 was ap-
plied. The macroscopic current immediately declined to 
an indiscernible level. A similar observation was made with 
E1371S-CFTR, a hydrolysis-deficient mutant with an open 
time of 100 s (Fig. 5 B). Fig. 5 C shows the dose–response 
relationships of CFTRinh-172 for WT-CFTR locked open 
with ATP and PPi (green circles), or E1371S-CFTR 
locked open with ATP (blue squares). Indeed, the dose–
response curve shifts further to the left. It is technically 
difficult to assess the effect of CFTRinh-172 at a concen-
tration <5 nM because the inhibition at very low inhibi-
tor concentrations is extremely slow, so that the time 
course of CFTR inhibition by CFTRinh-172 is easily dis-
torted by current decrease as a result of channel run-
down. Therefore, we were not able to obtain a more 
complete dose response for locked-open WT channels. 
Nevertheless, the data shown in Fig. 5 C suggest an IC50 
of ≤10 nM. Besides a difference in IC50 for the inhibi-
tor, there is also a difference in maximal percent inhibi-
tion as seen in Fig. 5 C (>99% inhibition for locked-open 
channels vs. 90% for ATP-gated WT-CFTR).
Figure  3.  The  relationship  between  [CFTRinh-172]  and  the 
closing  rate.  Mean  open  times  at  different  concentrations  of 
CFTRinh-172 were obtained from single-channel kinetic analysis, 
as described in Materials and methods. Each data point represents 
values determined from 7–10 patches. This relationship follows a 
saturation function, suggesting the existence of an additional step 
after the binding of the inhibitor to the open channel.
Figure 4.  Prolonging the mean open time of CFTR increases the 
potency of CFTRinh-172. (A) Representative single-channel trace 
for D1370N-CFTR, a hydrolysis-deficient mutant with a mean open 
time of 1 s. (B) A continuous current recording showing a revers-
ible  inhibition  of  macroscopic  D1370N-CFTR  currents  by  1  µM 
CFTRinh-172. (C) Dose–response relationships of CFTRinh-172 for 
WT-CFTR gated by ATP or P-ATP and D1370N-CFTR gated by ATP. 
Note a graded leftward shift of the dose–response relationship as 
the mean open time is prolonged. The experimental data were fit-
ted with the Hill equation. Fitting parameters: for P-ATP–gated WT 
channels: IC50 = 0.37 ± 0.22 µM and Hill coefficient, n = 0.69 ± 0.38; 
for D1370N-CFTR: IC50 = 0.064 ± 0.007 µM and n = 1.26 ± 0.17. Data 
points represent the average values determined from 4–14 patches.664 CFTR inhibition by a thiazolidinone derivative
this construct to study kinetics of current recovery from 
inhibition when dephosphorylation is a concern.
The results in Figs. 5 and 6 are important in several 
aspects. First, the immediate decrease of the macroscopic 
currents upon the addition of CFTRinh-172 indicates 
that the channel can be readily inhibited from the open 
state as proposed in Scheme 1. Although the observation 
that the open time of ATP-gated WT-CFTR is shortened 
by CFTRinh-172 (Fig. 2) suggests a direct effect of 
current recovery phase, we often added PKA into the sys-
tem to ensure that the observed slow current recovery is 
not a result of dephosphorylation of CFTR. To further 
verify this slow recovery, we quantified this recovery phase 
using a phosphorylation-independent construct charac-
terized previously (i.e., E1371S mutation in a construct 
without the R domain, or E1371S/R; see Bompadre   
et al., 2005). Again, the time constant of the current re-
covery for E1371S/R is 6 min (Fig. 6, C and D). 
Because the activity of E1371S/R-CFTR is independent 
of phosphorylation, in the following sections we will use 
Figure  6.  Slow  recovery  from  inhibition  for  the  locked-open 
CFTR. (A–C) Representative traces showing recovery after inhi-
bition of locked-open CFTR channels by CFTRinh-172. (D) The 
diagram shows the average rate of recovery from inhibition by 
CFTRinh-172 for WT and E1371S CFTR locked in an open state. 
The rate of recovery for ATP-gated WT-CFTR was plotted for com-
parison. The mean rate constants of recovery are: 0.024 ± 0.003 s
1 
(n = 17) for ATP-gated WT-CFTR; 0.0042 ± 0.0011 s
1 (n = 10) 
for WT-CFTR locked in an open state with ATP plus PPi; 0.0026 ± 
0.0004 s
1 (n = 18) for E1371S; and 0.0039 ± 0.0005 s
1 (n = 18) 
for E1371S/R.
Figure  5.  Inhibition  of  locked-open  CFTR  by  CFTRinh-172. 
CFTR  channels  were  locked  into  an  open  state  by  using  ATP 
plus PPi for WT-CFTR (A) or ATP for E1371S-CFTR (B). Once 
a steady-state current was attained, CFTRinh-172 was applied. In 
either case, the current was inhibited nearly completely. During 
the activation period, the short flat and vertical lines are a re-
sult of saturation of the amplifier and subsequent changes in the 
amplifier gain. (C) Dose–response relationships of CFTRinh-172 
for WT-CFTR locked open by PPi (green symbols) and E1371S-
CFTR locked open with ATP (blue symbols). Each data point rep-
resents values determined from four to nine patches. The fitted 
dose–response curve for WT channels gated with ATP was shown 
for comparison (red line). Although an accurate curve fit for the 
dose response cannot be obtained for PPi locked-open channels, 
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closing of the gate by disrupting the NBD dimer. More 
likely, the two NBDs remain engaged (i.e., the ligand 
ATPs remain bound), whereas the current is inhibited. 
It is interesting to note that this reopening in the absence 
of ATP is reminiscent of one well-known phenomenon 
for the voltage-gated cation channels that inactivate af-
ter activation by depolarization. These inactivated chan-
nels can reopen transiently when the membrane potential 
is stepped to hyperpolarizing voltages, as the inactivated 
channel will sojourn to the open state before the activa-
tion gate closes (Ruppersberg et al., 1991).
The  other  important  kinetic  information  from  data 
shown in Fig. 7 is the rate of reopening upon removal of 
CFTRinh-172. It takes tens of seconds to observe the first 
reopening of the channels in Fig. 7. Thus, the inactivated 
state with both CFTRinh-172 and ATP bound is exceed-
ingly stable and can be considered an absorbing state.
Does CFTRinh-172 bind to the closed state?
As described above, a lack of an inverse relationship 
between IC50 and Po suggests that Scheme 1 where 
CFTRinh-172 only binds to the open state is incorrect, 
despite the fact that this scheme can explain the re-
opening of the inhibited channels in the absence of 
ATP (Fig. 7). More likely, CFTRinh-172 can also bind 
to the closed state. Again, E1371S-CFTR allows us to 
address this question. Fig. 8 shows a recording where a 
super-maximal concentration of CFTRinh-172 was ap-
plied for 20 s in the absence of ATP when the channels 
CFTRinh-172 on the open state, one can still argue that 
CFTRinh-172 binds only to the closed state, but the in-
hibitor-bound closed channel opens very slowly, and once 
it opens, the open time is short (Scheme 2). Although it 
remains possible that inhibitor-bound channels may open 
for a shorter time, Scheme 2 by itself cannot explain the 
immediate decrease of the current generated from locked-
open channels, as the mean open time for the locked-
open channels is tens to hundreds of seconds. Second, the 
dramatic leftward shift of the dose–response relationship 
for locked-open channels, however, also disapproves 
Scheme 1 because this scheme predicts that IC50 should 
be inversely proportional to Po (IC50  1/Po). As the Po 
of ATP-gated WT-CFTR is 40–50% of that for channels 
locked open with ATP and PPi, a twofold change of 
IC50 is expected if Scheme 1 is correct. Instead, we ob-
served a >100-fold change of IC50. Third, that IC50 for 
CFTRinh-172 is decreased to 10 nM as the open time is 
prolonged to tens of seconds suggests that stabilizing the 
open state somehow stabilizes the binding of CFTRinh-172. 
Fourth, the extremely stable inhibited state for channels 
locked in the open state provides a unique time window 
to address several kinetic questions concerning how 
CFTRinh-172 works, as described in the following sections.
Can the inhibited channel reopen without ATP?
We have shown above that CFTRinh-172 is unlikely to 
be a simple open pore blocker. One possible mechanism 
for CFTR inhibition by CFTRinh-172 could be promo-
tion of ATP dissociation and/or separation of the NBD 
dimer, as ATP-triggered NBD dimerization is responsi-
ble for channel opening (Vergani et al., 2005). In other 
words, CFTRinh-172 works by promoting the closure of 
the gate opened by ATP. This idea can be tested by re-
moving CFTRinh-172 in the absence of ATP once the 
locked-open  channels  are  inhibited.  If  the  inhibitor 
works by disengaging NBD dimers and thereby promot-
ing ATP dissociation, one would predict that, once in-
hibited, channels will need ATP to open again. Fig. 7 
shows such an experiment. Once E1371S-CFTR channels 
were activated with PKA and ATP, the channels were 
subsequently inhibited by applying 5 µM CFTRinh-172. 
The current was diminished within a few seconds. The 
inhibitor was then removed in the absence of ATP. 
One can clearly discern the reopening of at least four 
channels in this patch. It can also be seen that there are 
at least two types of openings in the absence of ATP. 
Some of those brief openings (Fig. 7, blue inset) proba-
bly represent ATP-independent events observed normally 
in the absence of ATP for E1371S-CFTR (Bompadre 
et al., 2005). On the other hand, the locked-open state 
is discernable by its characteristic long-lasting events 
with flickery closures (Fig. 7, red inset). Based on the 
idea  that  the  open  state  represents  an  NBD  dimer 
(Vergani et al., 2005; Zhou et al., 2006; Tsai et al., 2009), 
we conclude that CFTRinh-172 does not promote the 
Figure 7.  Reopening of inhibited E1371S-CFTR channels upon 
removing CFTRinh-172. A continuous recording of E1371S-CFTR, 
a hydrolysis-deficient mutant with a prolonged open time, shows 
reopening of the inhibited channels in the absence of ATP upon 
removal of CFTRinh-172. Note that the channels can reopen into 
the locked-open state. Because some of the reopened channels 
are expected to close during such a long recording in the absence 
of ATP, the number of reopened channels is underestimated if 
one simply counts the opening events. Similar observations were 
made in more than 30 patches.666 CFTR inhibition by a thiazolidinone derivative
what analogous to the closing of the inactivation gate of 
voltage-gated ion channels—the inactivation gate is not 
closed until the activation gate is opened (Armstrong, 
1971, 1974; Armstrong and Bezanilla, 1977).
Although the biphasic current response to ATP after 
the channels are exposed to CFTRinh-172 during the 
closed state was seen consistently, the relative magnitude 
of the initial current induced by ATP varies. In 12 patches, 
the ratio of the peak amplitude of the transient current 
to the original current is 0.38 ± 0.03. Nevertheless, in the 
continuous presence of ATP, the whole current recovery 
takes place very slowly, as those shown in Fig. 6, where the 
inhibitor was applied to the open channels. Fitting the 
time course of current recovery with a single-exponential 
function produces a rate constant of 0.0035 ± 0.0005 s
1, 
which is not different from the rate of current recovery 
for channels inhibited at an open state (i.e., Fig. 6). This 
result suggests that even when the inhibitor hits the 
closed state, ATP binding (which presumably engages the 
two NBDs) will render nearly all the channels absorbed 
in the energetically stable inactivated state.
Three implications from the results shown in Figs. 7 
and 8 are worth mentioning here. First, the similarity of 
these data to the inactivation (Fig. 8) and recovery from 
inactivation (Fig. 7) of voltage-gated channels implies the 
operation of two different gates, one controlled by ATP-
induced NBD dimerization and a second “inactivation” 
gate that closes after CFTRinh-172 binds to the channel. 
Second, the direct demonstration that CFTRinh-172 can 
bind to the closed state necessitates a modification of 
Scheme 1. Third, the relatively small amplitude of the 
peak current in the biphasic response shown in Fig. 8 sug-
gests that some of the inhibitor-bound closed channels do 
not respond to ATP. In other words, the inhibitor-bound 
closed state can travel to a different inactivated state. We 
therefore added to Scheme 1 two additional states, Cinh 
and I’inh, representing CFTRinh-172–bound closed state 
and inactivated CFTRinh-172–bound closed state, respec-
tively (Scheme 3 below). It should also be noted that Iinh 
and I’inh are fundamentally different in that, as described 
above, Iinh has both ATP and inhibitor that remain bound, 
whereas the I’inh state has not been exposed to ATP.
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are mostly closed. The inhibitor was removed for 2 s 
before ATP was added. If the inhibitor can only bind to 
the open state, ATP will lock open all of the channels 
because the inhibitor is no longer in the superfusion 
solution. On the other hand, if the inhibitor can bind to 
the closed state and the inhibitor-bound closed chan-
nels do not respond to ATP, one expects that ATP will 
not be able to elicit any current. Neither of these two 
scenarios holds. As seen in Fig. 8, the application of ATP 
induced a biphasic current change: an initial increase of 
the current, followed by step-wise shutdown of individual 
channels. This surprising result indicates that CFTRinh-172 
can bind to the closed state, as ATP fails to lock open the 
channel. The extremely slow recovery of the current 
after the biphasic response indicates that at the be-
ginning of the recovery phase, nearly all channels are 
absorbed in the stable inactivated state (see below for de-
tails). For the biphasic response itself, we propose that the 
CFTRinh-172–bound closed channel can be opened by 
ATP.  However,  unlike  inhibitor-free  E1371S  channels 
that are locked open by ATP, the current from inhibitor-
bound channels, first elicited by ATP, dropped by itself 
within a few seconds, as the inhibitor-bound open chan-
nels are now inactivated. Again, this observation is some-
Figure  8.  The binding and inhibition of CFTRinh-172 in the 
closed state of E1371S/R-CFTR channels. The inhibitor was ap-
plied for 20 s in the absence of ATP and was removed from the 
perfusion solution for 2 s before the application of ATP. Imme-
diately after the application of ATP, one can observe a transient 
current increase. However, subsequent spontaneous inactivation 
of open channels without the inhibitor in the perfusion solution 
suggests that the binding of the inhibitor does happen in the closed 
state. Subsequent recovery of the current in the presence of ATP 
took place very slowly. Fitting the recovery phase with an expo-
nential function generates a rate constant of 0.0035 ± 0.0005 s
1, 
n = 12, which is not different from the rate constant for inhibition 
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only inhibitor bound, is probably less stable because even 
after exposure of the closed channels to CFTRinh-172 
for 20 s, many channels can be still opened by ATP 
(Fig. 8). Thus, in Cinh↔I’inh, I’inh does not serve as an 
absorbing state. Perhaps when ATP is applied, I’inh will 
travel to the absorbing state, Iinh.
Scheme 3 depicts two exit pathways for the captive in-
activated  state,  Iinh:  one  “visible”  pathway  (Iinh→Oinh) 
where inactivated channels reopen first before they dis-
sipate into other states, and the other “invisible” path-
way (Iinh→I’inh), so called because no current will be 
seen during the recovery of the channels from Iinh. Al-
though the experimental results in Fig. 7 demonstrate 
the reopening upon washout of CFTRinh-172 in the ab-
sence of ATP, the next set of experiments will address 
specifically the invisible pathway.
Unlike the visible pathway, the invisible one involves 
only transitions through nonconducting states. Because 
we cannot “see” these events directly, the existence of this 
pathway can only be inferred if the visible one fails to ex-
plain the experimental data. If Scheme 3 is correct, once 
the channels are fully inhibited to Iinh, not all channels re-
cover visibly. This can be examined with the locked-open 
channels, as their reopenings are readily discernible. 
Fig. 9 A shows such an experiment in patches containing 
only a few channels so that the number of reopening 
events can be counted manually. Because the experimen-
tal protocol demands long stationary recordings, the 
phosphorylation-independent  R  construct  was  used. 
E1371S/R CFTR channels were opened with 1 mM ATP 
and then inhibited with 2 µM CFTRinh-172. After re-
moval of ATP and the inhibitor from the solution, only 
one channel reopened in 200 s of recording. However, 
subsequent application of ATP opened three channels. 
Thus, the total number of channels recovered from inac-
tivation exceeds the number of channels recovered from 
the reopening (or visible) pathway. Thus, some channels 
recover without going through the visible pathway.
In patches that generate macroscopic currents, one 
can test the existence of the pathway other than reopen-
ing  by  comparing  current  recovery  upon  removal  of 
CFTRinh-172 in the presence or absence of ATP. Our 
experiments show that recovery from inhibition is para-
doxically slowed down by the presence of ATP. In Fig. 9 B, 
one  can  see  that  2  min  after  the  inhibitor  was  re-
moved, 45.6 ± 3.6% (n = 16) of the initial current was 
obtained  with  ATP  when  the  washout  solution  con-
tained no ATP. On the other hand, if the washout solu-
tion contained ATP, 25.4 ± 2.8% (n = 10) of current 
recovery occurred (Fig. 6 C). The phenomenon can be 
explained based on Scheme 3. In the absence of ATP, 
there are several ways of dissipation from the absorptive 
state (Iinh): Iinh→Oinh→O→C, Iinh→Oinh→Cinh→C, and 
Iinh→I’inh→Cinh→C. Because both ATP and CFTRinh-172 
are removed from the system, most dissipative pathways 
are irreversible. In contrast, when the washout phase 
In this scheme (Scheme 3), three vertical transitions 
represent ATP-dependent gating. In theory, there should 
be at least ATP-free and ATP-bound closed states, but 
they are lumped together because millimolar concen-
trations of ATP were used in our experiments so that 
the binding step is mostly saturated. The two horizontal 
transitions on the left represent binding and unbinding 
of CFTRinh-172 for the open state and the closed state, 
respectively, whereas the two horizontal steps on the 
right represent inactivation and recovery from inactiva-
tion of the open and closed channels.
More  detailed  examination  of  this  scheme  can  be 
found in the supplemental text. Here, we will briefly sum-
marize how the results shown above lead to this scheme, 
and then demonstrate a few experiments to further sup-
port the validity of the scheme. First, our experiments 
demonstrate that CFTRinh-172 can bind to both the 
open state (Fig. 5) and the closed state (Fig. 8); i.e., 
O↔Oinh and C↔Cinh. The binding of CFTRinh-172 to 
either the open state (Fig. 5) or the closed state (Fig. 8) 
does not lead to inhibition directly; an additional step is 
required; i.e., Oinh↔Iinh and Cinh↔I’inh. Fig. 8 also shows 
that the inhibitor-bound closed channels can be opened 
by ATP; i.e., Cinh↔Oinh. Because the Iinh→Oinh transition 
takes at least tens of seconds (Fig. 7), it is likely that Iinh, 
a state in which both ATP and inhibitor remain bound, 
is energetically very stable. In contrast, I’inh, a state with 
Figure 9.  Recovery of inhibited channels bypasses the reopening 
step. (A) A continuous current trace of E1371S/R-CFTR chan-
nels showing that some of the inhibited channels recover from 
inhibition  without  reopening.  Similar  observations  were  made 
in seven patches containing two to four channels. (B) Faster re-
covery of inhibited E1371S/R-CFTR channels in the absence of 
ATP. 2 min after the removal of CFTRinh-172, more current can 
be elicited by ATP than that with ATP in the washout solution 
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and inhibitor-bound closed state is noted in our experi-
ments where CFTRinh-172 was applied at different times 
of the gating cycle. Although the binding of CFTRinh-172 
to the locked-open channels leads to an energetically cap-
tive inactivated “open” state, the inactivated “closed” state 
is not as stable because even after a long exposure of the 
closed channels to CFTRinh-172, a significant amount of 
the inhibitor-bound closed channels is not inactivated, as 
they can still be opened by ATP (Fig. 8).
The conclusion that the inactivated open state, Iinh, is 
extremely stable energetically is also supported by experi-
mental results on the recovery of inactivation. It takes 
tens of minutes for the current to recover upon washout 
of the inhibitor in the presence of ATP for the locked-
open channels. Even for WT-CFTR under normal ATP-
dependent gating, a time constant of 40 s for current 
recovery in the presence of ATP is surprisingly long con-
sidering that the open states (inhibitor-bound or inhibi-
tor-free) are allowed to close rapidly. Perhaps the most 
important observation underscoring this line of reason-
ing is the long duration before reopening is seen upon 
washout of CFTRinh-172 in the absence of ATP for locked-
open  channels.  Although  these  events  are  difficult  to 
quantify because of the small size of the signal, raw data 
shown in Figs. 7 and 9 A indicate that it takes tens to hun-
dreds of seconds to see the reopening events. Observing 
these reopening events in the absence of ATP allows us 
to conclude that the NBDs of the inactivated open state 
remain engaged even though the channel is no longer 
conducting. In other words, the opening of the chan-
nels in the absence of ATP suggests that ATP has yet to 
dissociate from NBDs. The long-lasting opening events 
also suggest that the NBD dimer is not separated (Vergani 
et al., 2005). Thus, the inhibitor does not work by dis-
rupting NBD dimers.
A minimum kinetic model for the action of CFTRinh-172
As described in the Results, our experimental data lead 
to a six-state kinetic model (Scheme 3). It should be noted 
that although the existence of each state in Scheme 3 
is supported by experimental observations, this model 
should be considered a minimum scheme. For exam-
ple, it does not include steps portraying the dissociation 
of CFTRinh-172 from the inhibited states (Iinh and I’inh). 
However, including those steps will have to imply that 
both the open state and the closed state can be inacti-
vated  in  the  absence  of  CFTRinh-172.  Although  this 
could be the case, so far we do not have direct evidence 
supporting this notion. We have also lumped together 
many closed states because we are using a millimolar 
concentration of ATP so that the ATP-binding step is 
nearly saturated.
In  the  supplemental  text,  we  demonstrate  at  least 
semi-quantitatively how Scheme 3 can duplicate most of 
our data. Here, we will qualitatively describe some inter-
esting features of this kinetic model. Although there are 
occurs in the presence of ATP, the reactions Iinh→I’inh 
and Oinh→Cinh are reversed and therefore two of the dis-
sipative pathways are greatly slowed down. Thus, only 
one pathway is left for the recovery after inhibition.
D I S C U S S I O N
In this study, we investigated the mechanism of CFTR 
inhibition by the thiazolidinone derivative, CFTRinh-172, 
a specific inhibitor identified by high-throughput screen-
ing assays (Ma et al., 2002). Here, we will first draw 
several model-independent conclusions based on our 
data and then discuss the validity and potential limita-
tions of the proposed kinetic scheme. Finally, we will 
speculate on the possible structural mechanism for the 
action of CFTRinh-172.
CFTRinh-172 as a gating modulator
Contrary to a previous report (Taddei et al., 2004), we 
found that CFTRinh-172 causes both a decrease in 
the open time and an increase in the closed time for 
WT-CFTR gated by ATP. This finding, together with the 
observation  that  CFTRinh-172  inhibits  locked-open 
CFTR  channels  without  a  significant  delay,  indicates 
that the inhibitor can bind to the open state. As the 
channels preexposed to CFTRinh-172 during the closed 
state respond to ATP differently than the channels with-
out preexposure, one has to conclude that CFTRinh-172 
can also bind to the closed state. Thus, the binding site 
for CFTRinh-172 is accessible in both the open state 
and the closed state.
Interestingly,  unlike  a  simple  pore-plugging  mecha-
nism, the binding of CFTRinh-172 to either the open 
state or the closed state does not cause immediate inhibi-
tion of the current. The hyperbolic relationship between 
[CFTRinh-172] and the closing rate suggests that an ad-
ditional step is required for the inhibitor-bound open 
state to travel to the inactivated state. This additional step 
may  reflect  a  conformational  change  initiated  by  the 
binding of the inhibitor. Our studies do not provide any 
information  on  the  exact  conformational  changes  in-
volved. It should also be noted that we cannot completely 
rule out the possibility that CFTRinh-172 binds to the 
pore, as a more complicated mechanism of blockade that 
involves a docking and a blocking step may explain some 
of our data (Zhou et al., 2001; Zhang et al., 2009). How-
ever, a lack of voltage dependence (Fig. 1) (Ma et al., 
2002; Taddei et al., 2004) is more in line with an alloste-
ric mechanism rather than simply plugging the pore.
One of the most striking observations is the correlation 
between the potency of CFTRinh-172 and the open time: 
the longer the open time, the lower the IC50. This result 
suggests that the action of CFTRinh-172 on the open state 
is different from its effect on the closed state, although, 
as described above, both states can bind the inhibitor. 
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preexposed to CFTRinh-172 yields current rise in two 
phases without the appearance of inactivation. It should 
be noted that this apparent inactivation can be seen 
with WT-CFTR if we slightly modify the protocol. Also 
seen in Fig. 10, when ATP is applied in the continuous 
presence of CFTRinh-172, an initial increase of the cur-
rent is followed by inactivation. This is simply because 
the presence of ATP and the inhibitor together shifts 
the reaction to favor the dominance of the Oinh state, 
which then dissipates into the Iinh state (see supplemen-
tal text for simulations).
Structural implications
As an ion channel, CFTR must possess a gate that con-
trols the ion permeation pathway. Numerous functional 
studies have provided compelling evidence that this ac-
tivation gate is controlled by ATP binding to CFTR’s two 
NBDs and subsequent dimerization of the ATP-bound 
NBDs (for review see Chen and Hwang, 2008; Hwang 
and Sheppard, 2009). However, being a member of the 
ABC transporter family, CFTR likely evolves from an ac-
tive transporter. Phylogenic analysis has classified CFTR 
into the ABCC subfamily, in which many members func-
tion to export organic anions (Dean and Annilo, 2005). 
If we accept the idea that the ancestor of CFTR is an ex-
porter, one can assume that this ancestor protein likely 
possesses two gates as a transporter requires. This primor-
dial protein will have its substrate-binding site accessible 
to the cytoplasmic side before ATP binds, and dimeriza-
tion of its two ATP-bound NBDs will trigger conforma-
tional changes that render the binding site exposed to the 
extracellular side. This classical alternating access model 
for a transporter has gained support from crystallographic 
studies  that  demonstrate  outward-facing  and  inward-
facing configurations of the TMDs of ABC proteins 
(Locher et al., 2002; Dawson and Locher, 2006, 2007; 
overall seven transitions between states in Scheme 3, 
they can be divided into three groups: three gating tran-
sitions between the open state and the closed state, two 
steps for the binding and unbinding of CFTRinh-172, 
and two steps for inactivation of inhibitor-bound open 
and closed channels. Because our functional assay does 
not directly measure binding and unbinding of the in-
hibitor, we do not know if the binding affinity differs 
between the open state and the closed state. Our data, 
however,  do  indicate  that  the  inactivated  open  state 
(Iinh) is more stable than the inactivated closed state. 
Thus, considering the four states on the right of Scheme 3, 
we can conclude that the opening of the activation gate 
by ATP facilitates inactivation, a phenomenon similar to 
the well-known observation for voltage-gated cation chan-
nels (Armstrong, 1971, 1974; Armstrong and Bezanilla, 
1977). Thermodynamic constraints then dictate that inac-
tivation promotes opening of the activation gate.
Scheme 3 also explains reopening of the locked-open 
channels in the absence of ATP upon washout of the 
inhibitor. This observation is analogous to the gating 
mechanism of some potassium channels where depolar-
ization-induced, inactivated channels reopen transiently 
upon hyperpolarization, as the inactivation gate opens 
before the activation gate closes (Ruppersberg et al., 
1991). If the activation gate is allowed to close and in-
deed closes much faster than recovery from the inacti-
vated state (Iinh), one will not see reopening. Scheme 3 
predicts just that: this reopening will only be seen with 
channels with a slow closing rate (e.g., locked-open 
channels). When the closing rate of the inactivated 
channels (Iinh→I’inh) is much faster than the rate of re-
opening from the inactivated open state (Iinh→Oinh), 
the recovery from inactivation will take place predomi-
nantly through the so-called “invisible pathway” (i.e., 
Iinh→I’inh→Cinh) upon removal of the inhibitor. Indeed, 
for WT-CFTR gated by ATP, removal of the inhibitor in 
the absence of ATP did not elicit any transient current 
response (unpublished data). On the other hand, for 
locked-open channels, the slow closing of the activation 
gate allows the inactivated open state to travel to the in-
hibitor-bound open state to become visible (i.e., Iinh→Oinh 
in Scheme 3).
In addition to the aforementioned differences be-
tween WT and E1371S channels regarding the mecha-
nism of recovery from inactivation, Scheme 3 also predicts 
differences in inactivation per se. For E1371S-CFTR, be-
cause the closing rate is much slower than the rate of 
inactivation (i.e., Oinh→Cinh << Oinh→Iinh), the applica-
tion of ATP to channels preexposed to CFTRinh-172 
(Fig. 8) will generate a biphasic current response as a 
result of Cinh→Oinh→Iinh. However, the same protocol, 
when used for WT-CFTR, will produce different results 
because the transition Oinh→Iinh is slow compared with 
other transitions that dissipate the Oinh state. Indeed, as 
seen in Fig. 10, the application of ATP to WT-CFTR 
Figure 10.  Inactivation of WT-CFTR by CFTRinh-172. A continu-
ous recording of WT-CFTR channels exposed to CFTRinh-172 
during the closed state. Phosphorylated channels were first ex-
posed to 5 µM CFTRinh-172 in the absence of ATP. In the con-
tinuous presence of the inhibitor, the application of 1 mM ATP 
elicited a biphasic current response with an apparent inactivation 
phase. In the same patch, when ATP was applied after the inhibi-
tor was removed, a different biphasic current response appeared 
(see supplemental text for simulated results based on Scheme 3).670 CFTR inhibition by a thiazolidinone derivative
open channels are inactivated more readily than the in-
hibitor-bound closed channels (see above).
No  doubt,  the  two-gate  hypothesis  proposed  here 
needs to be further tested. Because this idea is borrowed 
from the voltage-gated ion channel field, perhaps many 
of the strategies used previously to understand how volt-
age-gated cation channels activate and inactivate can be 
used to further examine this hypothesis.
We thank Wen-Chi Wu, Cindy Chu, and Shenghui Hu for technical 
assistance.  We  are  also  grateful  to  Dr.  Robert  Bridges,  Rosalind 
Franklin University of Medicine and Science, and Cystic Fibrosis 
Foundation Therapeutics for the supply of CFTRinh-172.
This work was supported by grants NIHR01DK55835 and 
NIHR01HL53455  (to  T.-C.  Hwang),  a  Postdoctoral  Fellowship   
(KOPEIK09F0) from Cystic Fibrosis Foundation (to Z. Kopeikin), 
and a research grant (KAKENHI22590212) from Japan Society for 
the Promotion of Science (to Y. Sohma). This investigation was con-
ducted in a facility constructed with support from Research Facilities 
Improvement Program (grant C06 RR-016489-01) from the National 
Center for Research Resources, National Institutes of Health.
Christopher Miller served as editor.
Submitted: 16 August 2010
Accepted: 18 October 2010
R E F E R E N C E S
Aleksandrov, A.A., L. Aleksandrov, and J.R. Riordan. 2002. Nucleoside 
triphosphate pentose ring impact on CFTR gating and hydrolysis. 
FEBS Lett. 518:183–188. doi:10.1016/S0014-5793(02)02698-4
Armstrong, C.M. 1971. Interaction of tetraethylammonium ion de-
rivatives with the potassium channels of giant axons. J. Gen. Physiol. 
58:413–437. doi:10.1085/jgp.58.4.413
Armstrong, C.M. 1974. Ionic pores, gates, and gating currents. Q. Rev. 
Biophys. 7:179–210. doi:10.1017/S0033583500001402
Armstrong, C.M., and F. Bezanilla. 1977. Inactivation of the sodium 
channel. II. Gating current experiments. J. Gen. Physiol. 70:567–
590. doi:10.1085/jgp.70.5.567
Bai, Y., M. Li, and T.C. Hwang. 2010. Dual roles of the sixth transmem-
brane segment of the CFTR chloride channel in gating and perme-
ation. J. Gen. Physiol. 136:293–309. doi:10.1085/jgp.201010480
Barrett, K.E., and S.J. Keely. 2000. Chloride secretion by the intes-
tinal epithelium: molecular basis and regulatory aspects. Annu. 
Rev. Physiol. 62:535–572. doi:10.1146/annurev.physiol.62.1.535
Bhattacharya, S.K. 1995. Cholera outbreaks: role of oral rehydra-
tion therapy. J. Indian Med. Assoc. 93:237–238.
Bompadre, S.G., J.H. Cho, X. Wang, X. Zou, Y. Sohma, M. Li, and 
T.C. Hwang. 2005. CFTR gating II: effects of nucleotide bind-
ing on the stability of open states. J. Gen. Physiol. 125:377–394. 
doi:10.1085/jgp.200409228
Bompadre, S.G., Y. Sohma, M. Li, and T.C. Hwang. 2007. G551D 
and G1349D, two CF-associated mutations in the signature se-
quences of CFTR, exhibit distinct gating defects. J. Gen. Physiol. 
129:285–298. doi:10.1085/jgp.200609667
Caci, E., A. Caputo, A. Hinzpeter, N. Arous, P. Fanen, N. Sonawane, A.S. 
Verkman, R. Ravazzolo, O. Zegarra-Moran, and L.J.V. Galietta. 2008. 
Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg
347 
mutagenesis. Biochem. J. 413:135–142. doi:10.1042/BJ20080029
Cai, Z., A. Taddei, and D.N. Sheppard. 2006. Differential sensitivity 
of the cystic fibrosis (CF)-associated mutants G551D and G1349D 
to potentiators of the cystic fibrosis transmembrane conductance 
regulator  (CFTR)  Cl
  channel.  J.  Biol.  Chem.  281:1970–1977. 
doi:10.1074/jbc.M510576200
Hollenstein et al., 2007; Hvorup et al., 2007; Pinkett et al., 
2007). Based on this idea, we have proposed that the di-
merization-opened activation gate of CFTR is located at 
the extracellular end of the TMD (Tsai et al., 2009; also 
see Csanády, 2010). Thus, during evolution, the other 
gate located at the intracellular end of the TMD for this 
ancestor protein is degenerated so that CFTR can func-
tion as an ion channel (Chen and Hwang, 2008).
Although our work does not provide direct evidence 
pointing to a definitive structural mechanism for the ac-
tion of CFTRinh-172, here we will discuss several possi-
bilities. First, because binding of CFTRinh-172 to the 
channel leads to complete shutdown of the single-chan-
nel current, one has to conclude that the pore is ob-
structed. This can be a result of a direct blockade of the 
pore by CFTRinh-172. As explained above, the inhibitor 
may dock to the superficial position of the pore before 
it  travels  to  a  deeper  position  to  block  chloride  ion 
movement through the permeation pathway. The ob-
servation that mutations of the R347 residue in the sixth 
transmembrane segment alter the apparent affinity for 
CFTRinh-172 appears to support this idea (Caci et al., 
2008), but these mutational effects could be secondary 
to changes in gating kinetics. Furthermore, the residue 
R347, mutations of which produce most changes in the 
apparent affinity, is not a pore-lining residue (Dawson 
et al., 1999; McCarty and Zhang, 2001; Ge et al., 2004; 
Bai et al., 2010). Furthermore, the idea that CFTRinh-172 
inhibits CFTR by plugging the pore is difficult to explain 
why ATP, which keeps the gate open, in fact slows down 
current recovery upon removal of the inhibitor.
Second, CFTRinh-172 may work by decoupling NBDs 
from the activation gate controlled by ATP-induced 
NBD dimerization. This decoupling hypothesis is not 
only difficult to substantiate (or disapprove) because of 
the nonspecific nature of this hypothesis, but it is also 
difficult to explain how this decoupling preferentially 
occurs in the open state versus the closed state. Perhaps 
more importantly, the decoupling hypothesis does not 
provide clear insights for further examining this idea 
through experimentation.
Third, part of the CFTR protein itself, like in the case 
of plugging the K
+ channel pore by the inactivation ball 
(Hoshi et al., 1990; Zagotta et al., 1990), blocks the per-
meation pathway upon the binding of CFTRinh-172. 
In light of the evolutionary relationship between CFTR 
channels and ABC transporters, and the fact that many 
of our data can be explained by the action of an inacti-
vation gate, this interesting possibility is worth consider-
ation. One can imagine that opening the activation gate 
by ATP will cause constriction of the intracellular end of 
TMDs, where the inhibitor blocks the pore. Regardless, 
this hypothesis predicts that the opening of the activa-
tion gate should facilitate the closing of the inactivation 
gate because during a transport cycle, these two gates 
are coupled. Our data indeed show that inhibitor-bound   Kopeikin et al. 671
Riordan, J.R., J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. 
Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J.L. Chou, et al. 1989. 
Identification of the cystic fibrosis gene: cloning and characteriza-
tion of complementary DNA. Science. 245:1066–1073. doi:10.1126/ 
science.2475911
Ruppersberg, J.P., R. Frank, O. Pongs, and M. Stocker. 1991. Cloned 
neuronal IK(A) channels reopen during recovery from inactivation. 
Nature. 353:657–660. doi:10.1038/353657a0
Schultz, B.D., A.K. Singh, D.C. Devor, and R.J. Bridges. 1999. 
Pharmacology of CFTR chloride channel activity. Physiol. Rev. 79: 
S109–S144.
Taddei, A., C. Folli, O. Zegarra-Moran, P. Fanen, A.S. Verkman, and 
L.J.V. Galietta. 2004. Altered channel gating mechanism for CFTR 
inhibition  by  a  high-affinity  thiazolidinone  blocker.  FEBS  Lett. 
558:52–56. doi:10.1016/S0014-5793(04)00011-0
Thiagarajah, J.R., and A.S. Verkman. 2003. CFTR pharmacology and 
its role in intestinal fluid secretion. Curr. Opin. Pharmacol. 3:594–599. 
doi:10.1016/j.coph.2003.06.012
Tsai, M.-F., H. Shimizu, Y. Sohma, M. Li, and T.-C. Hwang. 2009. State-
dependent modulation of CFTR gating by pyrophosphate. J. Gen. 
Physiol. 133:405–419. doi:10.1085/jgp.200810186
Van Goor, F., S. Hadida, and P.D.J. Grootenhuis. 2008. Pharmacological 
rescue of mutant CFTR function for the treatment of cystic fibrosis. 
Top. Med. Chem. 3:91–120. doi:10.1007/7355_2008_022
Van  Goor,  F.,  S.  Hadida,  P.D.  Grootenhuis,  B.  Burton,  D.  Cao,  T. 
Neuberger, A. Turnbull, A. Singh, J. Joubran, A. Hazlewood, et al. 
2009. Rescue of CF airway epithelial cell function in vitro by a CFTR 
potentiator, VX-770. Proc. Natl. Acad. Sci. USA. 106:18825–18830. 
doi:10.1073/pnas.0904709106
Vergani, P., A.C. Nairn, and D.C. Gadsby. 2003. On the mechanism 
of MgATP-dependent gating of CFTR Cl
 channels. J. Gen. Physiol. 
121:17–36. doi:10.1085/jgp.20028673
Vergani, P., S.W. Lockless, A.C. Nairn, and D.C. Gadsby. 2005. CFTR 
channel opening by ATP-driven tight dimerization of its nucleotide-
binding domains. Nature. 433:876–880. doi:10.1038/nature03313
Weinreich, F., J.R. Riordan, and G. Nagel. 1999. Dual effects of ADP 
and adenylylimidodiphosphate on CFTR channel kinetics show 
binding to two different nucleotide binding sites. J. Gen. Physiol. 
114:55–70. doi:10.1085/jgp.114.1.55
Welsh, M.J., and A.E. Smith. 1993. Molecular mechanisms of CFTR 
chloride channel dysfunction in cystic fibrosis. Cell. 73:1251–1254. 
doi:10.1016/0092-8674(93)90353-R
Welsh, M.J., B.W. Ramsey, F. Accurso, and G.R. Cutting. 2001. Cystic 
fibrosis.  In  The  Metabolic  and  Molecular  Basis  of  Inherited 
Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. 
McGraw-Hill Inc., New York. 5121–5188.
Zagotta, W.N., T. Hoshi, and R.W. Aldrich. 1990. Restoration of inacti-
vation in mutants of Shaker potassium channels by a peptide derived 
from ShB. Science. 250:568–571. doi:10.1126/science.2122520
Zhang, X.D., P.Y. Tseng, W.P. Yu, and T.Y. Chen. 2009. Blocking 
pore-open  mutants  of  CLC-0  by  amphiphilic  blockers.  J.  Gen. 
Physiol. 133:43–58. doi:10.1085/jgp.200810004
Zhou,  M.,  J.H.  Morais-Cabral,  S.  Mann,  and  R.  MacKinnon.  2001. 
Potassium channel receptor site for the inactivation gate and quater-
nary amine inhibitors. Nature. 411:657–661. doi:10.1038/35079500
Zhou, Z., S. Hu, and T.-C. Hwang. 2002. Probing an open CFTR 
pore with organic anion blockers. J. Gen. Physiol. 120:647–662. 
doi:10.1085/jgp.20028685
Zhou, Z., X. Wang, M. Li, Y. Sohma, X. Zou, and T.-C. Hwang. 2005. 
High affinity ATP/ADP analogues as new tools for studying CFTR 
gating. J. Physiol. 569:447–457. doi:10.1113/jphysiol.2005.095083
Zhou, Z., X. Wang, H.Y. Liu, X. Zou, M. Li, and T.-C. Hwang. 2006. The 
two ATP binding sites of cystic fibrosis transmembrane conductance 
regulator (CFTR) play distinct roles in gating kinetics and ener-
getics. J. Gen. Physiol. 128:413–422. doi:10.1085/jgp.200609622
Chen,  T.Y.,  and  T.C.  Hwang.  2008.  CLC-0  and  CFTR:  chloride 
channels  evolved  from  transporters.  Physiol.  Rev.  88:351–387. 
doi:10.1152/physrev.00058.2006
Chen, T.Y., M.F. Tsai, and T.C. Hwang. 2010. Structure and mecha-
nisms in chloride channels. In The Comprehensive Biophysics. 
E.H. Egelman, editor. Elsevier, New York. In press.
Cotten,  J.F.,  and  M.J.  Welsh.  1999.  Cystic  fibrosis-associated  mu-
tations  at  arginine  347  alter  the  pore  architecture  of  CFTR. 
Evidence for disruption of a salt bridge. J. Biol. Chem. 274:5429–
5435. doi:10.1074/jbc.274.9.5429
Csanády, L. 2000. Rapid kinetic analysis of multichannel records by 
a simultaneous fit to all dwell-time histograms. Biophys. J. 78:785–
799. doi:10.1016/S0006-3495(00)76636-7
Csanády, L. 2010. Degenerate ABC composite site is stably glued 
together by trapped ATP. J. Gen. Physiol. 135:395–398. doi:10 
.1085/jgp.201010443
Dawson, R.J., and K.P. Locher. 2006. Structure of a bacterial multidrug 
ABC transporter. Nature. 443:180–185. doi:10.1038/nature05155
Dawson, R.J., and K.P. Locher. 2007. Structure of the multidrug ABC 
transporter Sav1866 from Staphylococcus aureus in complex with   
AMP-PNP. FEBS Lett. 581:935–938. doi:10.1016/j.febslet.2007.01.073
Dawson, D.C., S.S. Smith, and M.K. Mansoura. 1999. CFTR: mecha-
nism of anion conduction. Physiol. Rev. 79:S47–S75.
Dean, M., and T. Annilo. 2005. Evolution of the ATP-binding cas-
sette (ABC) transporter superfamily in vertebrates. Annu. Rev. 
Genomics Hum. Genet. 6:123–142. doi:10.1146/annurev.genom.6 
.080604.162122
Ge, N., C.N. Muise, X. Gong, and P. Linsdell. 2004. Direct com-
parison  of  the  functional  roles  played  by  different  transmem-
brane regions in the cystic fibrosis transmembrane conductance 
regulator chloride channel pore. J. Biol. Chem. 279:55283–55289. 
doi:10.1074/jbc.M411935200
Hollenstein, K., D.C. Frei, and K.P. Locher. 2007. Structure of an ABC 
transporter in complex with its binding protein. Nature. 446:213–
216. doi:10.1038/nature05626
Hoshi,  T.,  W.N.  Zagotta,  and  R.W.  Aldrich.  1990.  Biophysical  and 
molecular mechanisms of Shaker potassium channel inactivation. 
Science. 250:533–538. doi:10.1126/science.2122519
Hvorup, R.N., B.A. Goetz, M. Niederer, K. Hollenstein, E. Perozo, and 
K.P. Locher. 2007. Asymmetry in the structure of the ABC trans-
porter-binding  protein  complex  BtuCD-BtuF.  Science.  317:1387–
1390. doi:10.1126/science.1145950
Hwang,  T.C.,  and  D.N.  Sheppard.  1999.  Molecular  pharmacol-
ogy of the CFTR Cl
 channel. Trends Pharmacol. Sci. 20:448–453. 
doi:10.1016/S0165-6147(99)01386-3
Hwang,  T.C.,  and  D.N.  Sheppard.  2009.  Gating  of  the  CFTR  Cl
 
channel  by  ATP-driven  nucleotide-binding  domain  dimerisation.  
J. Physiol. 587:2151–2161. doi:10.1113/jphysiol.2009.171595
Locher, K.P., A.T. Lee, and D.C. Rees. 2002. The E. coli BtuCD struc-
ture: a framework for ABC transporter architecture and mechanism. 
Science. 296:1091–1098. doi:10.1126/science.1071142
Ma,  T.,  J.R.  Thiagarajah,  H.  Yang,  N.D.  Sonawane,  C.  Folli,  L.J.V. 
Galietta, and A.S. Verkman. 2002. Thiazolidinone CFTR inhibitor 
identified by high-throughput screening blocks cholera toxin-in-
duced intestinal fluid secretion. J. Clin. Invest. 110:1651–1658.
McCarty, N.A., and Z.R. Zhang. 2001. Identification of a region of 
strong discrimination in the pore of CFTR. Am. J. Physiol. Lung Cell. 
Mol. Physiol. 281:L852–L867.
Muanprasat, C., N.D. Sonawane, D. Salinas, A. Taddei, L.J.V. Galietta, and 
A.S. Verkman. 2004. Discovery of glycine hydrazide pore-occluding 
CFTR inhibitors: mechanism, structure–activity analysis, and in vivo 
efficacy. J. Gen. Physiol. 124:125–137. doi:10.1085/jgp.200409059
Pinkett, H.W., A.T. Lee, P. Lum, K.P. Locher, and D.C. Rees. 2007. An 
inward-facing conformation of a putative metal-chelate-type ABC 
transporter. Science. 315:373–377. doi:10.1126/science.1133488